Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

14 Biotech Stocks Facing FDA Approval
TheStreet.com
Wednesday, April 7, 2010 - 10:01am
tags:
Cell Therapeutics, Pozen, AstraZeneca, Dendreon, InterMune, Questcor Pharmaceuticals, Novartis, Biogen Idec, Teva Pharmaceuticals, Merck Serono, Savient, Javelin, Alexza, Human Genome, Jazz Pharmaceuticals, Arena Pharmaceuticals, Vivus, Biodel
Drug Pipeline Pulse Check: Teva on a Tear
Seeking Alpha
Tuesday, April 6, 2010 - 3:53pm
tags:
Teva Pharmaceuticals, Abbott Laboratories, Amag Pharmaceuticals, AstraZeneca, Aeterna Zentaris, Cubist Pharmaceuticals, Keryx, KV Pharmaceutical, Eli Lilly, Novartis, Savient, Sanofi
Cephalon Acquires Ception
Yahoo/Zacks.com
Tuesday, April 6, 2010 - 3:26pm
tags:
Cephalon, Ception Therapeutics, M&A
Study: Sanofi's Multaq shouldn't be a first-line drug
Fierce Pharma
Tuesday, April 6, 2010 - 2:26pm
tags:
Sanofi, Multaq, atrial fibrillation
FDA Approves Reformulated OxyContin
WSJ Online
Tuesday, April 6, 2010 - 11:28am
tags:
FDA, oxycontin, Purdue
FDA approves Nycomed's TachoSil patch
Marketwatch
Tuesday, April 6, 2010 - 11:27am
tags:
TachoSil, Nycomed, FDA
Sinovac's 4Q profit surges on $28.2M in swine flu revenue, but results miss Street estimates
Yahoo/AP
Tuesday, April 6, 2010 - 11:05am
tags:
Sinovac, earnings, swine flu, vaccines
Rexahn seeks to advance Parkinson's drug
Bizjournals.com
Tuesday, April 6, 2010 - 9:35am
tags:
Rexahn, Parkinson's Disease, Serdaxin
Avanir shares jump 10% in pre-market action
Marketwatch
Tuesday, April 6, 2010 - 9:34am
tags:
Avanir, Zenvia
Crucial Time for Cell Therapeutics
Yahoo/Zacks.com
Tuesday, April 6, 2010 - 9:12am
tags:
Cell Therapeutics, pixantrone
Glaucoma drug focus inspires $20M A round for Altheos
Fierce Biotech
Tuesday, April 6, 2010 - 9:11am
tags:
Altheos, glaucoma
The Big ‘Disaster’ At KV Pharmaceuticals
Pharmalot
Tuesday, April 6, 2010 - 9:08am
tags:
KV Pharmaceutical, discrimination, fraud
Preparing Pharmaceutical Company Employees for the Impact of Healthcare Reform
Pharmareform
Tuesday, April 6, 2010 - 9:07am
tags:
healthcare reform
Crucell and Glaxo will combine malaria vaccines
Yahoo/AP
Tuesday, April 6, 2010 - 9:06am
tags:
GSK, Crucell, vaccines, malaria
Judge Holds Off Accepting Boston Scientific Unit’s Guilty Plea
Bloomberg
Tuesday, April 6, 2010 - 9:03am
tags:
Boston Scientific, defibrillators
Sanofi-Aventis settles additional Eloxatin suits
Marketwatch
Tuesday, April 6, 2010 - 8:57am
tags:
Sanofi, Eloxatin, patents
Japan's JCR Pharma Makes Deal With Glaxo
Investors.com
Tuesday, April 6, 2010 - 8:56am
tags:
JCR Pharma, Japan, GSK
If Pfizer Wants Mylan, It'll Get a Can of Worms As Well
BNET Pharma
Tuesday, April 6, 2010 - 8:55am
tags:
Pfizer, Mylan, Dey
Biotech Could Be Volatile
CNBC
Monday, April 5, 2010 - 8:19pm
tags:
Celgene
1 Month to Go! Is Dendreon a Buy?
Motley Fool
Monday, April 5, 2010 - 7:11pm
tags:
Dendreon, Provenge, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.